In an article titled “Add-on liraglutide effective in obese diabetes patients” (published August 18, 2015) the 1.8-mg dosage of liraglutide was incorrectly identified. The trade name is Saxenda.
In an article titled “Add-on liraglutide effective in obese diabetes patients” (published August 18, 2015) the 1.8-mg dosage of liraglutide was incorrectly identified. The trade name is Saxenda.
AT THE EULAR 2015 CONGRESS ROME (FRONTLINE MEDICAL NEWS) – Anti–tumor necrosis factor agents ...
SAN DIEGO (FRONTLINE MEDICAL NEWS) – Cutaneous squamous cell carcinomas from organ transplant recipients ...
AT SDEF HAWAII DERMATOLOGY SEMINAR KAUAI, HAWAII (FRONTLINE MEDICAL NEWS) – A fixed combination ...
